950 related articles for article (PubMed ID: 17015796)
21. Different patterns in donor-specific production of T-helper 1 and 2 cytokines by cells infiltrating the rejecting cardiac allograft.
van Besouw NM; Daane CR; Vaessen LM; Balk AH; Claas FH; Zondervan PE; Jutte NH; Weimar W
J Heart Lung Transplant; 1995; 14(5):816-23. PubMed ID: 8800715
[TBL] [Abstract][Full Text] [Related]
22. Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma.
Dajotoy T; Andersson P; Bjartell A; Löfdahl CG; Tapper H; Egesten A
J Leukoc Biol; 2004 Sep; 76(3):685-91. PubMed ID: 15197236
[TBL] [Abstract][Full Text] [Related]
23. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts.
Lee EM; Park JO; Kim D; Kim JY; Oh KH; Park CG; Oh BH; Kim S; Ahn C
Xenotransplantation; 2006 Jul; 13(4):328-36. PubMed ID: 16768726
[TBL] [Abstract][Full Text] [Related]
24. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
[TBL] [Abstract][Full Text] [Related]
25. Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin.
Atkinson C; Horsley J; Rhind-Tutt S; Charman S; Phillpotts CJ; Wallwork J; Goddard MJ
J Heart Lung Transplant; 2004 Apr; 23(4):427-35. PubMed ID: 15063402
[TBL] [Abstract][Full Text] [Related]
26. Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.
Krakauer M; Sorensen PS; Khademi M; Olsson T; Sellebjerg F
Scand J Immunol; 2006 Aug; 64(2):155-63. PubMed ID: 16867161
[TBL] [Abstract][Full Text] [Related]
27. Elevated serum levels of the CXCR3 chemokine ITAC are associated with the development of transplant coronary artery disease.
Kao J; Kobashigawa J; Fishbein MC; MacLellan WR; Burdick MD; Belperio JA; Strieter RM
Circulation; 2003 Apr; 107(15):1958-61. PubMed ID: 12695288
[TBL] [Abstract][Full Text] [Related]
28. Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts.
Lu WH; Palatnik K; Fishbein GA; Lai C; Levi DS; Perens G; Alejos J; Kobashigawa J; Fishbein MC
J Heart Lung Transplant; 2011 Sep; 30(9):1044-50. PubMed ID: 21640617
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of chemokines and chemokine receptors during microglial activation and inhibition.
Kremlev SG; Roberts RL; Palmer C
J Neuroimmunol; 2004 Apr; 149(1-2):1-9. PubMed ID: 15020059
[TBL] [Abstract][Full Text] [Related]
30. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts.
Isse K; Harada K; Zen Y; Kamihira T; Shimoda S; Harada M; Nakanuma Y
Hepatology; 2005 Mar; 41(3):506-16. PubMed ID: 15726664
[TBL] [Abstract][Full Text] [Related]
31. Chemokine and toll-like receptor signaling in macrophage mediated islet xenograft rejection.
Chandra AP; Ouyang L; Yi S; Wong JK; Ha H; Walters SN; Patel AT; Stokes R; Jardine M; Hawthorne WJ; O'Connell PJ
Xenotransplantation; 2007 Jan; 14(1):48-59. PubMed ID: 17214704
[TBL] [Abstract][Full Text] [Related]
32. Induction of surface CCR4 and its functionality in mouse Th2 cells is regulated differently during Th2 development.
Morimoto Y; Bian Y; Gao P; Yashiro-Ohtani Y; Zhou XY; Ono S; Nakahara H; Kogo M; Hamaoka T; Fujiwara H
J Leukoc Biol; 2005 Sep; 78(3):753-61. PubMed ID: 16126843
[TBL] [Abstract][Full Text] [Related]
33. Chemokine gene expression during allograft rejection: comparison of two quantitative PCR techniques.
Carvalho-Gaspar M; Billing JS; Spriewald BM; Wood KJ
J Immunol Methods; 2005 Jun; 301(1-2):41-52. PubMed ID: 16018884
[TBL] [Abstract][Full Text] [Related]
34. AP-1 and STAT-1 decoy oligodeoxynucleotides attenuate transplant vasculopathy in rat cardiac allografts.
Stadlbauer TH; Wagner AH; Hölschermann H; Fiedel S; Fingerhuth H; Tillmanns H; Bohle RM; Hecker M
Cardiovasc Res; 2008 Sep; 79(4):698-705. PubMed ID: 18511434
[TBL] [Abstract][Full Text] [Related]
35. Intimal fibrosis in human cardiac allograft vasculopathy.
Huibers M; De Jonge N; Van Kuik J; Koning ES; Van Wichen D; Dullens H; Schipper M; De Weger R
Transpl Immunol; 2011 Sep; 25(2-3):124-32. PubMed ID: 21782945
[TBL] [Abstract][Full Text] [Related]
36. Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL-10-/- mice and Rag-2-/- mice reconstituted with CD4+CD45RBhigh T cells.
Scheerens H; Hessel E; de Waal-Malefyt R; Leach MW; Rennick D
Eur J Immunol; 2001 May; 31(5):1465-74. PubMed ID: 11465103
[TBL] [Abstract][Full Text] [Related]
37. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.
Zeremski M; Petrovic LM; Talal AH
J Viral Hepat; 2007 Oct; 14(10):675-87. PubMed ID: 17875002
[TBL] [Abstract][Full Text] [Related]
38. Establishment of murine model of allergic photocontact dermatitis to ketoprofen and characterization of pathogenic T cells.
Imai S; Atarashi K; Ikesue K; Akiyama K; Tokura Y
J Dermatol Sci; 2006 Feb; 41(2):127-36. PubMed ID: 16226877
[TBL] [Abstract][Full Text] [Related]
39. Increased Th1 activity in patients with coronary artery disease.
Fernandes JL; Mamoni RL; Orford JL; Garcia C; Selwyn AP; Coelho OR; Blotta MH
Cytokine; 2004 May; 26(3):131-7. PubMed ID: 15135807
[TBL] [Abstract][Full Text] [Related]
40. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.
Jalonen TO; Pulkkinen K; Ukkonen M; Saarela M; Elovaara I
J Neurol; 2002 May; 249(5):576-83. PubMed ID: 12021948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
